Cash Pricing Success Story: Sandpoint Super Drug
Learn how one pharmacy used RxCash+ to lessen the stress of cash pricing and spend more time on patient care.
What’s the problem with cash prescriptions? Often, it boils down to missed revenue and wasted time from manual pricing. Most pharmacies lack control of profitable, competitive cash pricing. They have no pricing standardization and are often delayed by heavy workloads in responding to the changing market – after all, $4 lists don’t reflect current conditions anymore.
Because DIY cash pricing consumes major time and resources at the same time that its volume is growing, many pharmacies are looking for a better way. Sandpoint Super Drug, profiled here, is just one of many success stories for RxCash+ from RedSail Technologies.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
